par Byl, Baudouin
;Clevenbergh, Philippe;Kentos, Alain
;Jacobs, Frédérique
;Marchant, Arnaud
;Vincent, Jean Louis
;Thys, Jean-Pierre 
Référence European journal of clinical microbiology & infectious diseases, 20, 11, page (804-807)
Publication Publié, 2001-11






Référence European journal of clinical microbiology & infectious diseases, 20, 11, page (804-807)
Publication Publié, 2001-11
Article révisé par les pairs
Titre: |
|
Auteur: | Byl, Baudouin; Clevenbergh, Philippe; Kentos, Alain; Jacobs, Frédérique; Marchant, Arnaud; Vincent, Jean Louis; Thys, Jean-Pierre |
Informations sur la publication: | European journal of clinical microbiology & infectious diseases, 20, 11, page (804-807) |
Statut de publication: | Publié, 2001-11 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Bacteremia -- blood |
Bacteremia -- drug therapy | |
Ceftazidime -- administration & dosage | |
Drug Administration Schedule | |
Endotoxins -- blood | |
Female | |
Gram-Negative Bacterial Infections -- blood | |
Gram-Negative Bacterial Infections -- drug therapy | |
Humans | |
Imipenem -- administration & dosage | |
Injections, Intravenous | |
Interleukin-6 -- blood | |
Male | |
Probability | |
Reference Values | |
Sensitivity and Specificity | |
Statistics, Nonparametric | |
Tumor Necrosis Factor-alpha -- analysis | |
Note générale: | Clinical Trial |
Comparative Study | |
Journal Article | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0934-9723 |
info:doi/10.1007/s100960100609 | |
info:scp/0035663083 | |
info:pmid/11783697 |